{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:09:34Z","timestamp":1788307774527,"version":"build-2803163510"},"reference-count":31,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9,1]]},"abstract":"<jats:p>Concerns about possible allergic reactions to immunizations are raised frequently by both patients\/parents and primary care providers. Estimates of true allergic, or immediate hypersensitivity, reactions to routine vaccines range from 1 per 50000 doses for diphtheria-tetanus-pertussis to \u223c1 per 500000 to 1000000 doses for most other vaccines. In a large study from New Zealand, data were collected during a 5-year period on 15 marketed vaccines and revealed an estimated rate of 1 immediate hypersensitivity reaction per 450000 doses of vaccine administered. Another large study, conducted within the Vaccine Safety Datalink, described a range of reaction rates to &amp;gt;7.5 million doses. Depending on the study design and the time after the immunization event, reaction rates varied from 0.65 cases per million doses to 1.53 cases per million doses when additional allergy codes were included. For some vaccines, particularly when allergens such as gelatin are part of the formulation (eg, Japanese encephalitis), higher rates of serious allergic reactions may occur. Although these per-dose estimates suggest that true hypersensitivity reactions are quite rare, the large number of doses that are administered, especially for the commonly used vaccines, makes this a relatively common clinical problem. In this review, we present background information on vaccine hypersensitivity, followed by a detailed algorithm that provides a rational and organized approach for the evaluation and treatment of patients with suspected hypersensitivity. We then include 3 cases of suspected allergic reactions to vaccines that have been referred to the Clinical Immunization Safety Assessment network to demonstrate the practical application of the algorithm.<\/jats:p>","DOI":"10.1542\/peds.2008-1002","type":"journal-article","created":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T13:27:57Z","timestamp":1220275677000},"page":"e771-e777","source":"Crossref","is-referenced-by-count":100,"title":["An Algorithm for Treatment of Patients With Hypersensitivity Reactions After Vaccines"],"prefix":"10.1542","volume":"122","author":[{"given":"Robert A.","family":"Wood","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin","family":"Berger","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and Medicine, University Hospitals of Cleveland, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Dreskin","sequence":"additional","affiliation":[{"name":"Division of Allergy and Immunology, University of Colorado Health Sciences Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Setse","sequence":"additional","affiliation":[{"name":"Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata J.M.","family":"Engler","sequence":"additional","affiliation":[{"name":"Vaccine Healthcare Center Network, Walter Reed Army Medical Center, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia L.","family":"Dekker","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal A.","family":"Halsey","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Hypersensitivity Working Group of the Clinical Immunization Safety Assessment (CISA) Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2008,9,1]]},"reference":[{"key":"2021120905265560300_R1","unstructured":"American Academy of Pediatrics. Active immunization. In: Pickering LK, Baker CJ, Long SS, McMillan JA, eds. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006:446\u2013448"},{"key":"2021120905265560300_R2","doi-asserted-by":"crossref","unstructured":"Zent O, Arras-Reiter C, Broeker M, Hennig R. Immediate allergic reactions after vaccinations: a post-marketing surveillance review. Eur J Pediatr.\u20082002;161(1):21\u201325","DOI":"10.1007\/s00431-001-0853-0"},{"key":"2021120905265560300_R3","doi-asserted-by":"crossref","unstructured":"Bohlke K, Davis RL, Marcy SM, et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics.\u20082003;112(4):815\u2013820","DOI":"10.1542\/peds.112.4.815"},{"key":"2021120905265560300_R4","unstructured":"Inactivated Japanese encephalitis virus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep.\u20081993;42(RR-1):1\u201315"},{"key":"2021120905265560300_R5","doi-asserted-by":"crossref","unstructured":"Georgitis JW, Fasano MB. Allergenic components of vaccines and avoidance of vaccination-related adverse events. Curr Allergy Rep.\u20082001;1(1):11\u201317","DOI":"10.1007\/s11882-001-0091-6"},{"key":"2021120905265560300_R6","doi-asserted-by":"crossref","unstructured":"Patrizi A, Rizzoli L, Vincenzi C, et al. Sensitization to thimerosal in atopic children. Contact Dermatitis.\u20081999;40(2):94\u201397","DOI":"10.1111\/j.1600-0536.1999.tb05998.x"},{"key":"2021120905265560300_R7","doi-asserted-by":"crossref","unstructured":"Ponvert C, Ardelean-Jaby D, Colin-Gorski AM, et al. Anaphylaxis to the 23-valent pneumococcal vaccine in child: a case-control study based on immediate responses in skin tests and specific IgE determination. Vaccine.\u20082001;19(32):4588\u20134591","DOI":"10.1016\/S0264-410X(01)00257-2"},{"key":"2021120905265560300_R8","doi-asserted-by":"crossref","unstructured":"Fasano MB, Wood RA, Cooke SK, Sampson HA. Egg hypersensitivity and adverse reactions to measles, mumps, and rubella vaccine. J Pediatr.\u20081992;120(6):878\u2013881","DOI":"10.1016\/S0022-3476(05)81953-5"},{"key":"2021120905265560300_R9","doi-asserted-by":"crossref","unstructured":"Kelso JM, Jones RT, Yuninger JW. Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin. J Allergy Clin Immunol.\u20081993;91(4):867\u2013871","DOI":"10.1016\/0091-6749(93)90344-F"},{"key":"2021120905265560300_R10","doi-asserted-by":"crossref","unstructured":"Kumagai T, Yamanaka T, Wataya Y, et al. Gelatin-specific humoral and cellular immune responses in children with immediate- and nonimmediate-type reactions to live measles, mumps, rubella, and varicella vaccines. J Allergy Clin Immunol.\u20081997;100(1):130\u2013134","DOI":"10.1016\/S0091-6749(97)70204-5"},{"key":"2021120905265560300_R11","doi-asserted-by":"crossref","unstructured":"Kumagai T, Ozaki T, Kamada M, et al. Gelatin-containing diphtheria-tetanus-pertussis (DTP) vaccine causes sensitization to gelatin in the recipients. Vaccine.\u20082000;18(15):1555\u20131561","DOI":"10.1016\/S0264-410X(99)00441-7"},{"key":"2021120905265560300_R12","doi-asserted-by":"crossref","unstructured":"Nakayama T, Aizawa C, Kuno-Sakai H. A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids. J Allergy Clin Immunol.\u20081999;103(2 pt 1):321\u2013325","DOI":"10.1016\/S0091-6749(99)70508-7"},{"key":"2021120905265560300_R13","doi-asserted-by":"crossref","unstructured":"James JM, Zeiger RS, Lester MR, et al. Safe administration of influenza vaccine to patients with egg allergy. J Pediatr.\u20081998;133(5):624\u2013628","DOI":"10.1016\/S0022-3476(98)70101-5"},{"key":"2021120905265560300_R14","doi-asserted-by":"crossref","unstructured":"Kelso JM, Mootrey GT, Tsai TF. Anaphylaxis from yellow fever vaccine. J Allergy Clin Immunol.\u20081999;103(4):698\u2013701","DOI":"10.1016\/S0091-6749(99)70245-9"},{"key":"2021120905265560300_R15","doi-asserted-by":"crossref","unstructured":"Purello-D'Ambrosio F, Gangemi S, La Rosa G, et al. Allergy to gelatin. Allergy.\u20082000;55(4):414\u2013415","DOI":"10.1034\/j.1398-9995.2000.00618.x"},{"key":"2021120905265560300_R16","doi-asserted-by":"crossref","unstructured":"Sakaguchi M, Yamanaka T, Ikeda K, et al. IgE-mediated systemic reactions to gelatin included in the varicella vaccine. J Allergy Clin Immunol.\u20081997;99(2):263\u2013264","DOI":"10.1016\/S0091-6749(97)70108-8"},{"key":"2021120905265560300_R17","doi-asserted-by":"crossref","unstructured":"Sakaguchi M, Inouye S. Two patterns of systemic immediate-type reactions to Japanese encephalitis vaccines. Vaccine.\u20081998;16(1):68\u201369","DOI":"10.1016\/S0264-410X(97)00152-7"},{"key":"2021120905265560300_R18","doi-asserted-by":"crossref","unstructured":"Sakaguchi M, Nakayama T, Inouye S. Cases of systemic immediate-type urticaria associated with acellular diphtheria-tetanus-pertussis vaccination. Vaccine.\u20081998;16(11\u201312):1138\u20131140","DOI":"10.1016\/S0264-410X(98)80111-4"},{"key":"2021120905265560300_R19","doi-asserted-by":"crossref","unstructured":"Sakaguchi M, Inouye S. IgE sensitization to gelatin: the probable role of gelatin-containing diphtheria-tetanus-acellular pertussis (DTaP) vaccines. Vaccine.\u20082000;18(19):2055\u20132058","DOI":"10.1016\/S0264-410X(99)00480-6"},{"key":"2021120905265560300_R20","doi-asserted-by":"crossref","unstructured":"Sakaguchi M, Miyazawa H, Inouye S. Specific IgE and IgG to gelatin in children with systemic cutaneous reactions to Japanese encephalitis vaccines. Allergy.\u20082001;56(6):536\u2013539","DOI":"10.1034\/j.1398-9995.2001.056006536.x"},{"key":"2021120905265560300_R21","doi-asserted-by":"crossref","unstructured":"Sakaguchi M, Miyazawa H, Inouye S. Sensitization to gelatin in children with systemic non-immediate-type reactions to varicella vaccines. Ann Allergy Asthma Immunol.\u20082000;84(3):341\u2013344","DOI":"10.1016\/S1081-1206(10)62784-6"},{"key":"2021120905265560300_R22","doi-asserted-by":"crossref","unstructured":"Sakaguchi M, Nakayama T, Fujita H, et al. Minimum estimated incidence in Japan of anaphylaxis to live virus vaccines including gelatin. Vaccine.\u20082000;19(4\u20135):431\u2013436","DOI":"10.1016\/S0264-410X(00)00206-1"},{"key":"2021120905265560300_R23","doi-asserted-by":"crossref","unstructured":"Singer S, Johnson CE, Mohr R, Holowecky C. Urticaria following varicella vaccine associated with gelatin allergy. Vaccine.\u20081999;17(4):327\u2013329","DOI":"10.1016\/S0264-410X(98)00209-6"},{"key":"2021120905265560300_R24","doi-asserted-by":"crossref","unstructured":"DiMiceli L, Pool V, Kelso JM, Shadomy SV, Iskander J, V.A.E.R.S. Team. Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS) Vaccine.\u20082006;24(6):703\u2013707","DOI":"10.1016\/j.vaccine.2005.07.069"},{"key":"2021120905265560300_R25","doi-asserted-by":"crossref","unstructured":"Russell M, Pool V, Kelso JM, Tomazic-Jezic V. Vaccination of persons allergic to latex: a review of safety data in the Vaccine Adverse Event Reporting System (VAERS). Vaccine.\u20082004;23(5):664\u2013667","DOI":"10.1016\/j.vaccine.2004.06.042"},{"key":"2021120905265560300_R26","doi-asserted-by":"crossref","unstructured":"Ru\u0308ggeberg JU, Gold MS, Bayas J-M, et al. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine.\u20082007;25(31):5675\u20135684","DOI":"10.1016\/j.vaccine.2007.02.064"},{"key":"2021120905265560300_R27","unstructured":"Askenase P. Delayed-type hypersensitivity and cellular immunity. In: Adkinson NF, Yunginger JY, Busse W, Bochner B, Holgate ST, Simons FE, eds. Allergy Principles and Practice. 6th ed. St Louis, MO: Mosby; 2003:425\u2013452"},{"key":"2021120905265560300_R28","unstructured":"Kroger AT, Atkinson WL, Marcuse EK, Pickering LK; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) [published corrections appear in MMWR Morb Mortal Wkly Rep. 2006;55(48):1303; MMWR Morb Mortal Wkly Rep. 2007;56(11):256; Pediatrics. 2007;119(5):1008]. MMWR Recomm Rep.\u20082006;55(RR-15):1\u201348"},{"key":"2021120905265560300_R29","doi-asserted-by":"crossref","unstructured":"Wood RA, Setse R, Halsey N. Assessment of irritant skin tests reactions to common vaccines. J Allergy Clin Immunol.\u20082007;120(2):478\u2013481","DOI":"10.1016\/j.jaci.2007.04.035"},{"key":"2021120905265560300_R30","doi-asserted-by":"crossref","unstructured":"Sugai K, Shiga A, Okada K, et al. Dermal testing of vaccines for children at high risk of allergies. Vaccine.\u20082007;25(17):3454\u20133463","DOI":"10.1016\/j.vaccine.2006.12.057"},{"key":"2021120905265560300_R31","unstructured":"Canter LM. Anaphylactoid reactions to radiocontrast media. Allergy Asthma Proc.\u20082005;26(3):199\u2013203"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/122\/3\/e771\/1175766\/zpe0090800e771.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/122\/3\/e771\/1175766\/zpe0090800e771.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T22:55:43Z","timestamp":1639090543000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/122\/3\/e771\/72320\/An-Algorithm-for-Treatment-of-Patients-With"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,1]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,9,1]]},"published-print":{"date-parts":[[2008,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2008-1002","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,1]]}}}